Main Second Level Navigation
From morphology to molecules: the evolving story of neurofibromatosis type1-associated solid tumors
As part of our LMP Seminar Series we are delighted to welcome our speaker:
Dr. Fausto Rodriguez
Professor, Department of Laboratory Medicine and Pathobiology
University of California, Los Angeles
Talk title: "From morphology to molecules: the evolving story of neurofibromatosis type1-associated solid tumors"
Hosted by
How to join
The event will be in person, no need to register. Students and trainees must attend in person.
For faculty members who need to attend remotely, please register to receive the zoom link. Registration must be received by noon on Tuesday.
If you have any questions, please contact lmp.chairadmin@utoronto.ca for more details.
Wednesday, November 4, 2026
11 am - 12 pm
MSB 2170
Medical Sciences Building
University of Toronto
1 King’s College Circle
Toronto, ON M5S 1A8
Details are sent to the LMP community in the Friday events bulletin.
Speaker bio: Dr. Fausto Rodriguez
Dr. Fausto Rodriguez is a Professor and Chief of Neuropathology at the University of California Los Angeles David Geffen School of Medicine and UCLA Health. He also currently serves as director of the pathology core for the brain cancer SPORE at UCLA.
Dr. Rodriguez received his MD from the University of Missouri-Columbia and completed his residency training in Anatomic and Neuropathology at the Mayo Clinic in Rochester, Minnesota, where he also completed a Masters in Biomedical Science. Later, Dr. Rodriguez completed a fellowship in Molecular Genetic Pathology at Johns Hopkins University, where he also served as Director of Neuropathology from 2010 to 2021.
His research interests focus on the pathology of brain, ocular, and peripheral nerve tumours and the identification of novel markers for diagnosis and treatment of these diseases. In particular, he has worked in the past decade to identify diagnostic, prognostic, and therapeutic biomarkers and targets of nervous system tumors developing in children and in patients with inherited tumor syndromes, particularly neurofibromatosis type 1.
Dr. Rodriguez has also contributed chapters to various WHO classifications of CNS tumours and textbooks. Most recently, he is co-author with Professor Cynthia Hawkins of a new edition of the AFIP fascicle on Tumours of the Central Nervous System. Together, these publications have helped to establish the standard for pathology diagnosis around the world.